文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

从综合角度看肠道微生物群与 COVID-19 疫苗的相互作用。

A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.

机构信息

Institute of Advanced Diagnostic and Clinical Medicine, Zhongshan City People's Hospital, Zhongshan, China.

Department of Anesthesiology, Zhongshan City People's Hospital, Zhongshan, China.

出版信息

Gut Microbes. 2023 Jan-Dec;15(1):2233146. doi: 10.1080/19490976.2023.2233146.


DOI:10.1080/19490976.2023.2233146
PMID:37431857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10337507/
Abstract

The efficacy of COVID-19 vaccines varies between individuals and populations, and the reasons for this are still not fully understood. Recent clinical studies and animal models have indicated that the gut microbiota may influence the immunogenicity of the vaccine and, thus, its effectiveness. This suggests that there is a bidirectional relationship between the gut microbiota and the COVID-19 vaccine, with the varying components of the microbiota either enhancing or reducing the vaccine's efficacy. To put an end to the spread of the COVID-19 pandemic, the necessity of vaccines that create powerful and long-term immunity is now more important than ever, and understanding the role of the gut microbiota in this process is essential. Conversely, COVID-19 vaccines also have a significant effect on the gut microbiota, decreasing its total number of organisms and the variety of species present. In this Review, we analyze the evidence that suggesting an interaction between the gut microbiota and COVID-19 vaccine effectiveness, consider the immunological mechanisms that may be responsible for this connection, and explore the possibility of using gut microbiota-focused interventions to improve the efficacy of COVID-19 vaccines.

摘要

新型冠状病毒肺炎(COVID-19)疫苗在个体和人群之间的有效性存在差异,其原因仍不完全清楚。最近的临床研究和动物模型表明,肠道微生物群可能会影响疫苗的免疫原性,从而影响其有效性。这表明肠道微生物群和 COVID-19 疫苗之间存在双向关系,微生物群的不同成分可能增强或降低疫苗的效力。为了终结 COVID-19 大流行的传播,现在比以往任何时候都更需要能够产生强大和长期免疫力的疫苗,而了解肠道微生物群在这一过程中的作用至关重要。相反,COVID-19 疫苗也会对肠道微生物群产生重大影响,减少其总生物数量和存在的物种多样性。在这篇综述中,我们分析了表明肠道微生物群和 COVID-19 疫苗有效性之间存在相互作用的证据,考虑了可能导致这种联系的免疫机制,并探讨了使用以肠道微生物群为重点的干预措施来提高 COVID-19 疫苗效力的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/88ba30e0cdd6/KGMI_A_2233146_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/f15d31b7b5de/KGMI_A_2233146_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/ded8aa2dfe34/KGMI_A_2233146_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/383aa66a6c19/KGMI_A_2233146_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/62b799b23ed2/KGMI_A_2233146_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/28158e60a630/KGMI_A_2233146_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/24b527cbc33c/KGMI_A_2233146_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/2d8c2b7b5c39/KGMI_A_2233146_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/88ba30e0cdd6/KGMI_A_2233146_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/f15d31b7b5de/KGMI_A_2233146_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/ded8aa2dfe34/KGMI_A_2233146_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/383aa66a6c19/KGMI_A_2233146_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/62b799b23ed2/KGMI_A_2233146_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/28158e60a630/KGMI_A_2233146_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/24b527cbc33c/KGMI_A_2233146_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/2d8c2b7b5c39/KGMI_A_2233146_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10337507/88ba30e0cdd6/KGMI_A_2233146_F0008_OC.jpg

相似文献

[1]
A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.

Gut Microbes. 2023

[2]
Interaction between gut microbiota and COVID-19 and its vaccines.

World J Gastroenterol. 2022-10-28

[3]
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms.

Nat Rev Immunol. 2022-1

[4]
Targeting gut microbiota for immunotherapy of diseases.

Arch Toxicol. 2024-8

[5]
Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.

Curr Drug Targets. 2022

[6]
Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.

JAMA Netw Open. 2021-9-1

[7]
Influence of Microbiota on Vaccine Effectiveness: "Is the Microbiota the Key to Vaccine-induced Responses?".

J Microbiol. 2023-5

[8]
Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine.

Cell Rep Med. 2022-10-18

[9]
Host factors and vaccine efficacy: Implications for COVID-19 vaccines.

J Med Virol. 2022-4

[10]
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.

Life Sci Alliance. 2024-2-5

引用本文的文献

[1]
The emerging role of the gut microbiota in vaccination responses.

Gut Microbes. 2025-12

[2]
Immunomodulatory effects of gut microbiota on vaccine efficacy against respiratory pathogens.

Front Immunol. 2025-6-3

[3]
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia.

Biomark Res. 2025-2-10

[4]
Impact of an intranasal L-DBF vaccine on the gut microbiota in young and elderly mice.

Gut Microbes. 2024

[5]
Exploring the associations between gut microbiota composition and SARS-CoV-2 inactivated vaccine response in mice with type 2 diabetes mellitus.

mSphere. 2024-9-25

[6]
Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.

MedComm (2020). 2024-3-15

[7]
Mapping the landscape of research on insulin resistance: a visualization analysis of randomized clinical trials.

J Health Popul Nutr. 2024-1-9

本文引用的文献

[1]
Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8.

Virol J. 2023-5-29

[2]
Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study.

J Clin Med. 2023-5-18

[3]
Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals.

Viral Immunol. 2023-6

[4]
Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study).

Nutrients. 2023-4-20

[5]
Host-Specific Diversity of Culturable Bacteria in the Gut Systems of Fungus-Growing Termites and Their Potential Functions towards Lignocellulose Bioconversion.

Insects. 2023-4-21

[6]
Role of gut symbionts of insect pests: A novel target for insect-pest control.

Front Microbiol. 2023-3-13

[7]
Determinants of COVID-19 vaccination acceptance or hesitancy in Italy: an overview of the current evidence.

Ann Ist Super Sanita. 2023

[8]
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.

Lancet. 2023-4-22

[9]
Durability of immune responses to mRNA booster vaccination against COVID-19.

J Clin Invest. 2023-5-15

[10]
SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.

J Med Virol. 2023-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索